Tag: Rajiv Nath
AiMeD welcomes govt’s GST rate cut & MRP implementation relief for...
Recalling or re-labelling of existing stock already released in the market will not be mandatory
India’s rise to 4th largest economy will boost manufacturing & MedTech:...
We must ensure that this economic rise translates into meaningful development at the grassroots level, across rural and urban India alike
AIMeD calls Budget 2025 as disappointing for medical devices industry
As per the industry body, there is no investment promotion measure for the 70% imports dependent Medical Devices Sector
MedTech industry associations accuse environment ministry of medical devices policy violations
Domestic manufacturers raise concerns about the ministry officials' confused policies, which pose a threat to the growth of the 'Make in India' initiative and the vision of a self-reliant India
Budget 2024: AiMeD hails budget, calls it a boost to overall...
AiMeD Forum Coordinator Rajiv Nath says the medical devices industry was expecting more for quality and affordable healthcare
AiMeD & DRISP collaboration gives boost to Indo Russian medical device...
The experts from India and Russia stressed the need for a dynamic and multifaceted economic engagement at a recently held webinar
India gets a national policy on Pharma-MedTech R&D, Rs 5,000 Crore...
We need to transform Indian Pharma & MedTech sectors from a cost-based to a value-based & innovation-based industry, outlines Health Minister Dr Mansukh Mandaviya
HMD supplied 1.75 billion syringes for Covid-19 vaccination globally
Nearly 1 covid vaccine in every 7-8 people worldwide was administered using syringe manufactured by Hindustan Syringes & Medical Devices
AiMeD applauds govt’s latest MedTech policy decisions
These include National Medical Devices Policy 2023; Medical Devices Export Promotion Council; and Scheme for Assistance to Medical Devices Clusters for common facility
Industry lauds National Medical Devices Policy 2023 as a significant milestone
The leading associations and companies have welcomed the approval to the policy that outlines critical strategies such as regulatory simplification, infrastructure development, R&D, innovation facilitation and much more